# Servicebio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/servicebio

- Industry: Medical Devices & Equipment
- Headquarters: Wuhan, China
- Website: www.servicebio.cn
- Latest round: Series A (Jul 3, 2020)
- Investors on record: 1

## About

Founded in 2015 and based in Wuhan, China, Servicebio operates as a medical company that focuses on experimental service and the production of scientific research reagents. It was recognized as the National High-tech Enterprise. The company has branch offices in Beijing, Shanghai, Guangzhou, and other cities. In July 2020, Servicebio closed a series A funding from new investor TTGG Asset Management. 

Servicebio provides reagents, consumables, instruments, and testing services. Its experimental service involves pathology experiments, animal experiments, cell experiments, protein antibodies, and special staining. The reagents include commonly used reagent consumables, commonly used secondary antibodies, commonly used stains, and a full set of reagents for WB assay. Products have served life science research institutions, research institutes, in vitro diagnostics, and biopharmaceutical companies.

The company generates revenue by selling scientific research reagents and providing experimental services.

## Funding rounds

- Series A, Jul 3, 2020 — TTGG Ventures

## Investors

- TTGG Ventures (https://capitalatlas.ai/funds/ttgg-ventures) — Series A